AposHealth

AposHealth AposHealth® (previously AposTherapy®) is a global leader in the identification and treatment of gait-related conditions

AposHealth® (previously AposTherapy®) is a global leader in the identification and treatment of gait-related conditions. The AposHealth®’s foot-worn “Apos3” device is FDA-cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA cleared wellness device which can help patients live well with other gait-related conditions such as chronic low back and hip pain. With a mission to advance global health through the power of movement, AposHealth®’s latest business unit AposIQ, combines innovative technology, data science and over a decade of experience in gait modification to determine the optimal way to adjust patients’ gaits over time. Since 2005, AposHealth® has been making it possible for patients in the US, UK, and Israel, to develop better movement patterns and get back to doing the things they love.

Powerful infograph showing how osteoarthritis is crippling the British workforce. http://bit.ly/1arQZrL
02/06/2014

Powerful infograph showing how osteoarthritis is crippling the British workforce. http://bit.ly/1arQZrL

According to the CDC, 50 million people in the US are affected with arthritis and nearly 1 in 2 people will develop symptomatic knee osteoarthritis (OA) within their lifetime. With the combination of the aging Baby Boomer population, increased longevity of US citizens and the obesity epidemic, the r...

One of our patients at the beach with her AposTherapy device, on a sunny day, being herself again!
01/07/2014

One of our patients at the beach with her AposTherapy device, on a sunny day, being herself again!

AposTherapy Chief Medical Officer and Co-Founder, Dr. Amit Mor with UK Prime Minister David Cameron at TechCity UK’s 3rd...
12/09/2013

AposTherapy Chief Medical Officer and Co-Founder, Dr. Amit Mor with UK Prime Minister David Cameron at TechCity UK’s 3rd anniversary.

AposTherapy was honored to be among the select international companies recognized, with regards to our contribution to the UK healthcare market. AposTherapy, with the assistance and support of UKTI, chose to set up the European headquarters in the UK in 2010 and since then opened centres in London, Manchester, Birmingham, Edinburgh, Kent and Sussex.

(Photo: Ayelet Mavor)

11/21/2013

Enjoy this video explaining the innovative technology behind AposTherapy and how it works!

Has your osteoarthritis pain effected your ability to work? You are not alone, a poll done by AposTherapy shows that in ...
11/12/2013

Has your osteoarthritis pain effected your ability to work? You are not alone, a poll done by AposTherapy shows that in the UK 1 in 10 osteoarthritis sufferers aged 55 and over say it has affected their work, with two thirds having to quit working. http://dailym.ai/16YUEcS

A poll by AposTherapy, a knee and lower back pain therapy company, found one in ten osteoarthritis sufferers say the condition has affected their work.

AposTherapy co-founder and Chief Medical Office, Dr. Amit Mor speaking at the General Assembly for the Jewish Federation...
11/11/2013

AposTherapy co-founder and Chief Medical Office, Dr. Amit Mor speaking at the General Assembly for the Jewish Federations of North America

Address

300 Park Avenue
New York, NY
10022

Alerts

Be the first to know and let us send you an email when AposHealth posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram